Method and composition for administering an NMDA receptor antagonist to a subject
US8168209B2 · kind B2 · utility
33Cited by
44References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2009 |
| Grant date | May 1, 2012 |
| Priority date | — |
| Expiry date | Mar 25, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.